Reflections on Attribution and Decisions in Pharmacovigilance Ola CasterI. Ralph Edwards Editorial 09 January 2013 Pages: 805 - 809
How to Apply the Human Factor to Periodic Safety Update Reports Brian David EdwardsGiovanni Furlan Current Opinion 09 January 2013 Pages: 811 - 820
Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder Gary StiefelFrank M.C. Besag Review Article 09 January 2013 Pages: 821 - 842
Proton Pump Inhibitors and Fracture Risk Michael BodmerChristian MeierChristoph R. Meier Review Article 09 January 2013 Pages: 843 - 852
Nature, Occurrence and Consequences of Medication-Related Adverse Events During Hospitalization Lilian H.F. HoonhoutMartine C. de BruijneMaurits W. van Tulder Short Communication 09 January 2013 Pages: 853 - 864
Mapping the Safety Profile of Biologicals Thijs J. GiezenAukje K. Mantel-TeeuwisseToine C.G. Egberts Original Research Article 09 January 2013 Pages: 865 - 878
Drug-Drug Interactions in Cardiac and Cardiothoracic Intensive Care Units Pamela L. SmithburgerSandra L. Kane-GillAmy L. Seybert Original Research Article 09 January 2013 Pages: 879 - 888
Pharmacovigilance Activities in Nepal Subish PalaianMohamed Izham Mohamed IbrahimBhupendra Bahadur Thapa Correspondence 09 January 2013 Pages: 889 - 890